Cannabichromene (CBC) is a non-intoxicating cannabinoid found in the cannabis plant. While it is not as well-known as other cannabinoids like THC or CBD, recent research has suggested that CBC may have a range of potential health benefits.
One of the most promising areas of research for CBC is its potential as an anti-inflammatory agent. In a study published in the British Journal of Pharmacology, researchers found that CBC had significant anti-inflammatory effects, and could be a promising therapeutic agent for conditions such as arthritis and other inflammatory diseases.
The key results of the study are:
- Cannabichromene activated CB2 receptors, but not CB1 receptors, in AtT20 cells.
- This activation was inhibited by a CB2 receptor antagonist, AM630, and sensitive to Pertussis toxin.
- Application of Cannabichromene reduced activation of CB2 receptors, but not CB1 receptors, by subsequent co-application of CP55,940, an efficacious CB, and CB2 receptor agonist.
- Continuous Cannabichromene application induced loss of cell surface CB2 receptors and desensitization of the CB2 receptor-induced hyperpolarization.
The conclusions and implications of the study are:
- Cannabichromene is a selective CB2 receptor agonist, meaning it activates CB2 receptors but not CB1 receptors.
- Cannabichromene is more effective than tetrahydrocannabinol (THC) at hyperpolarizing AtT20 cells.
- Cannabichromene can recruit CB2 receptor regulatory mechanisms, which means it can cause the body to change the way it responds to CB2 receptor activation.
- Cannabichromene may contribute to the potential therapeutic effects of some cannabis preparations, potentially through CB2 receptor-mediated modulation of inflammation.
In plain English, this means that CBC is a compound found in cannabis that activates CB2 receptors, but not CB1 receptors. CB2 receptors are involved in the body’s immune response, and activation of CB2 receptors can have anti-inflammatory effects. This suggests that CBC may have potential therapeutic benefits for inflammatory diseases, such as arthritis and Crohn’s disease.
However, it is important to note that this study was conducted in cells in a laboratory setting, and further research is needed to confirm these findings in humans.
In addition to its potential as an anti-inflammatory, CBC has also been found to have antifungal and antibacterial properties. A study published in Biomedicines – An Open Access Journal from MDPI found that CBC had potential anti-microbial effects, and could be a useful tool in potential treatments for antibiotic-resistant infections.
CBC may also have potential as a pain reliever. In a study published in the British Journal of Pharmacology, researchers found that CBC had significant analgesic (pain-relieving) effects in mice. While more research is needed to determine its efficacy in humans, this suggests that CBC may be useful for managing pain in certain conditions.
Finally, CBC may have the potential as an anti-cancer agent. In a study published by The Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, researchers found that CBC inhibited the growth of cancer cells in vitro, and could be a promising agent for the prevention and treatment of breast cancer.
While more research is needed to understand the potential health benefits of CBC fully, early studies suggest that it may be a valuable addition to our arsenal of natural health remedies. If you’re interested in exploring the potential benefits of CBC, consider incorporating CBC-rich cannabis strains or CBC oil into your wellness routine. As always, be sure to speak with your healthcare provider before making any changes to your health regimen.
Discover additional information regarding our Cannabis School based in Grenada, located in the West Indies.
CBD.how powers our educational resources.
Join our Mimea Cannabis Community and elevate your experience to that of a High Achiever.